Akebia Therapeutics, Inc.

AKBA · XNAS

CIK 1517022fmd_0MMKASNA1G3MPHMBQNFA86KZMHManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2026, 56 periods

Ratios computed from the standardized statements. Select a value to open its proof.